Back to Search Start Over

Targeting A β and p-Tau Clearance in Methamphetamine-Induced Alzheimer's Disease-Like Pathology: Roles of Syntaxin 17 in Autophagic Degradation in Primary Hippocampal Neurons.

Authors :
Zhu Y
Wang X
Hu M
Yang T
Xu H
Kang X
Chen X
Jiang L
Gao R
Wang J
Source :
Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2022 May 18; Vol. 2022, pp. 3344569. Date of Electronic Publication: 2022 May 18 (Print Publication: 2022).
Publication Year :
2022

Abstract

Methamphetamine (Meth), a central nervous system (CNS) stimulant with strong neurotoxicity, causes progressive cognitive impairment with characterized neurodegenerative changes. However, the mechanism underlying Meth-induced pathological changes remains poorly understood. In the current study, Meth elicited a striking accumulation of the pathological proteins hyperphosphorylated tau (p-tau) and amyloid beta (A β ) in primary hippocampal neurons, while the activation of autophagy dramatically ameliorated the high levels of these pathological proteins. Interestingly, after the Meth treatment, A β was massively deposited in autophagosomes, which were remarkably trapped in early endosomes. Mechanistically, syntaxin 17 (Stx17), a key soluble n-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptor (SNARE) protein responsible for autophagosome and mature endosome/lysosome fusion, was significantly downregulated and hindered in combination with autophagosomes. Notably, adenovirus overexpression of Stx17 in primary neurons facilitated autophagosome-mature endosome/lysosome fusion, which dramatically reversed the Meth-induced increases in the levels of p-tau, A β , beta-secretase (Bace-1), and C-terminal fragments (CTFs). Immunofluorescence assays showed that Stx17 retarded the Meth-induced A β , p-tau, and Bace-1 accumulation in autophagosomes and facilitated the translocation of these pathological proteins to lysosomes, which indicated the importance of Stx17 via enhanced autophagosome-mature endosome/lysosome fusion. Therefore, the current study reveals a novel mechanism involving Meth-induced high levels of pathological proteins in neurons. Targeting Stx17 may provide a novel therapeutic strategy for Meth-induced neurodegenerative changes.<br />Competing Interests: The authors declare that they have no conflict of interest.<br /> (Copyright © 2022 Yuanhui Zhu et al.)

Details

Language :
English
ISSN :
1942-0994
Volume :
2022
Database :
MEDLINE
Journal :
Oxidative medicine and cellular longevity
Publication Type :
Academic Journal
Accession number :
35633882
Full Text :
https://doi.org/10.1155/2022/3344569